The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Cellmid (CDY) has received import permits allowing the sale of its Jo-Ju and Lexilis-branded shampoos in mainland China
  • Based in Sydney, Cellmid is a health and beauty company leveraging innovative anti-aging technologies
  • The permits, issued by the Chinese National Medical Products Administration, are essential for the sale of fully finished products in China
  • The documents allow CDY to progress its 10-year distribution deal with Ourui Health Management
  • Cellmid shares are up 2.94 per cent, trading at 7 cents each

Cellmid (CDY) has received import permits allowing the sale of its Jo-Ju and Lexilis-branded shampoos in mainland China.

Based in Sydney, Cellmid is a health and beauty business leveraging innovative anti-aging technologies.

The permits, issued by the Chinese National Medical Products Administration (NMPA), are essential for the sale of fully finished products in China.

Cellmid says the receipt of the documents is a key milestone in implementing its 10-year distribution agreement signed with Ourui Health Management in December last year.

The permits do not have an expiry date and will remain valid subject to Cellmid’s compliance with NMPA’s annual reporting requirements.

On the market this afternoon, Cellmid shares are up 2.94 per cent, trading at 7 cents at 1:17 pm AEST.

CDY by the numbers
More From The Market Online

What it takes to get a new drug to market in Australia

In this latest version of Thematica from TMO, we're taking a break from mines and battery…

4DMedical partners with West Los Angeles VA Medical Center for Veteran lung imaging study

Respiratory imaging technology company, 4DMedical (ASX:4DX) has entered into a research agreement with the West Los…

Recce Pharma picks up Chinese patent for anti-infective drugs

Recce Pharmaceuticals (ASX:RCE) has confirmed its receipt of a patent in China to protect its class…

BlinkLab partnership with US smart-tech Turning Pointe raises hopes for autism kids

BlinkLab partners with US-based Turning Pointe Autism Foundation for clinical study ahead of its FDA registration…